0
0
0
Advancing Research for Chronic Pain Act of 2023
12/15/2023, 4:09 PM
Summary of Bill S 2922
Bill 118 s 2922, also known as the Advancing Research for Chronic Pain Act of 2023, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to advance research efforts related to chronic pain in order to improve treatment options and outcomes for individuals suffering from this condition.
If passed, the bill would authorize funding for research initiatives focused on chronic pain, including studies on the underlying causes of chronic pain, potential treatments, and ways to improve the quality of life for those affected by chronic pain. The bill also aims to promote collaboration among researchers, healthcare providers, and patients in order to better understand and address the complexities of chronic pain.
Additionally, the Advancing Research for Chronic Pain Act of 2023 includes provisions to enhance education and training for healthcare professionals in the diagnosis and management of chronic pain. This would help ensure that individuals with chronic pain receive appropriate and effective care from knowledgeable providers. Overall, this bill seeks to address the significant impact of chronic pain on individuals, families, and society as a whole by supporting research efforts and promoting better care for those living with chronic pain. It represents a bipartisan effort to improve the lives of millions of Americans who are affected by this debilitating condition.
If passed, the bill would authorize funding for research initiatives focused on chronic pain, including studies on the underlying causes of chronic pain, potential treatments, and ways to improve the quality of life for those affected by chronic pain. The bill also aims to promote collaboration among researchers, healthcare providers, and patients in order to better understand and address the complexities of chronic pain.
Additionally, the Advancing Research for Chronic Pain Act of 2023 includes provisions to enhance education and training for healthcare professionals in the diagnosis and management of chronic pain. This would help ensure that individuals with chronic pain receive appropriate and effective care from knowledgeable providers. Overall, this bill seeks to address the significant impact of chronic pain on individuals, families, and society as a whole by supporting research efforts and promoting better care for those living with chronic pain. It represents a bipartisan effort to improve the lives of millions of Americans who are affected by this debilitating condition.
Read the Full Bill
Current Status of Bill S 2922
Bill S 2922 is currently in the status of Bill Introduced since September 26, 2023. Bill S 2922 was introduced during Congress 118 and was introduced to the Senate on September 26, 2023. Bill S 2922's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of September 26, 2023
Bipartisan Support of Bill S 2922
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
6Democrat Cosponsors
2Republican Cosponsors
4Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 2922
Primary Policy Focus
HealthComments
Sponsors and Cosponsors of S 2922
Latest Bills
ARCA Act of 2025
Bill S 1591December 24, 2025
SPEED Act
Bill HR 4776December 24, 2025
Medal of Sacrifice Act
Bill HR 3497December 24, 2025
Public Lands Military Readiness Act of 2025
Bill HR 5131December 24, 2025
National Defense Authorization Act for Fiscal Year 2026
Bill S 1071December 23, 2025
VetPAC Act of 2025
Bill S 787December 23, 2025
A resolution commemorating 30 years of diplomatic relations between the United States and Vietnam on July 11, 2025.
Bill SRES 321December 23, 2025
Reliable Power Act
Bill HR 3616December 23, 2025
Protect Children’s Innocence Act
Bill HR 3492December 23, 2025
Pet and Livestock Protection Act
Bill HR 845December 23, 2025
SUPPORT for Patients and Communities Reauthorization Act
Bill S 3393March 5, 2024



